iv vitamin c tauranga

iv vitamin c tauranga

iv vitamin c quackwatch

Iv Vitamin C Tauranga

CLICK HERE TO CONTINUE




Has your doctor told you that all your tests are normal but you still don’t feel well? It’s time to take a fresh look at the way your health is managed – to take back control and get back to how you should feel. Our aim is to provide as holistic a care as is humanly possible. We’ve evaluated lots of different therapies and the ones that we use are constantly evolving as new knowledge comes to hand. Our strength lies in never accepting that people’s ill health are a lost cause. There is a reason that you have all of these symptoms, and the better that we understand this, the better chance you have of being healed. We use our expertise in general medicine, applied kinesiology, acupuncture (treating musculoskeletal disorders only), nutrition, toxicology, sports medicine and stress management to help you to get better. You should notice improvements within a few months. We have a wide skill set that differs from normal doctors . We are constantly doing research which is driven by our desire to help as many people as possible with difficult problems.




Louise, Kate and I have differing perspectives and skills that we can combine to help you NB: There are 2 Borman Rd’s and they do not meet. Please use the one off Resolution Drive if you are coming from Hamilton West (Te Rapa) or off Moonlight Drive if you are coming from Hamilton East All general inquiries and orders This web store is available only to patients of Dr Steve Joe Integrative Medicine. Find a Practitioner - New ZealandAustralasian College of Nutritional and Environmental MedicineVitamin therapy fails to deliver for Sir Paul Celebrated physicist Sir Paul Callaghan has ended his experimental intravenous vitamin-C treatment for cancer, saying there is "absolutely no evidence" it worked. He is concerned that alternative medicine advocates are now using his "unusual experiment" to promote the controversial treatment in a misleading way. The New Zealander of the Year, who has terminal colon cancer, began receiving high-dose intravenous infusions of vitamin C in June last year, along with several alternative herbal remedies.




The 64-year-old began the treatment during a six-month break from chemotherapy, tracking its effectiveness through a blood test for protein carcinoembryonic antigen (CEA), which indicates cancer levels. Yesterday, he told The Dominion Post he had ended his experiment after analysing data from six months of blood test results. "I have, as a result, learned enough to say that there is absolutely no evidence of any beneficial effect of high-dose intravenous vitamin C in my case." His CEA had initially dropped after the first six doses of vitamin C, but had then risen again. He said he wanted to make the results of his experiment public because of the risk his use of vitamin C would be used to falsely promote the therapy. "I've been deluged with correspondence from people who have wanted me to endorse products, try products. That was a really negative side." The way people promoted products without evidence was "quite repellent", he said. He had seen his name cited in articles promoting vitamin C and said he knew publicity about his experiment had caused other people to try it.




People with cancer had the right to try unproven therapies themselves, but should do so in consultation with their specialist or GP, he said. "In my case, I have done so openly, with the knowledge of my medical advisers, and with the sort of dispassionate scepticism that you would expect of a scientist. I was never advocating this treatment. I was just curious." He is now receiving radiotherapy and discussing other treatment options with his doctor. Victoria University professor Shaun Holt, a natural remedies researcher, said he was not surprised the treatment had not worked, "though I really wish it had". Debate about high-dose vitamin C had been raging for three decades and it was time proper clinical trials were conducted, he said. "I don't think it does [work], but I'm always happy to be corrected. "Sir Paul is such a high-profile, well-respected person. It would be great if he could use that profile to initiate the funding for a trial." High-dose vitamin C has been steadily gaining publicity in New Zealand.




Young Wellington film-maker Kurt Filiga tracked his unsuccessful treatment in a documentary he made before his death from leukaemia in September 2010. Last year, an unnamed Wellington doctor who gives intravenous vitamin C told The Dominion Post that an estimated 30 clinics nationwide gave 10,000 injections of vitamin C a year. - The Dominion Post Douglas RM, Hemila H, D'Souza R, et al. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000980. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proceeding of the National Academy of Sciences 1976; Creagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. New England Journal of Medicine 1979; Moertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy.




A randomized double-blind comparison. New England Journal of Medicine 1985; Tschetter L, et al. A community-based study of vitamin C (ascorbic acid) in patients with advanced cancer. Proceedings of the American Society of Clinical Oncology 1983;2:92. Kuiper C, Molenaar IGM, Dachs GU, et al. Low Ascorbate Levels Are Associated with Increased Hypoxia-Inducible Factor-1 Activity and an Aggressive Tumor Phenotype in Endometrial Cancer. Living Proof: Vitamin C – Miracle Cure?  Download the PDF version of this article (69.6 KB)October 4, 2013 | By Dr. Ronald Hoffman Download this page in PDF formatFor more than 20 years, the Hoffman Center has been using high-dose vitamin C drips in its cancer support protocols. The initial impetus was from Linus Pauling who, together with Ewan Cameron, pioneered the use of high-dose C in cancer in the 1960s. Now, there’s new interest in this modality for fighting cancer based on new, exciting research under way at the National Institutes of Health.




Cameron and Pauling found that vitamin C helped cancer patients live about four times longer than cancer patients not given vitamin C. They administered high-dose vitamin C in the form of sodium ascorbate given orally and intravenously to treat more than 1,000 cancer patients. Nonetheless, vitamin C for cancer suffered a setback when Dr. Charles Moertel of the Mayo Clinic, an arch foe of nutritional therapies for cancer, sought to disprove Pauling’s thesis. But he did not follow the Pauling/Cameron instructions or regimen. Moertel selected a cohort of terminal colon cancer patients who had not responded to all forms of conventional treatment, including surgery, chemo and radiation, and administered 10 grams of vitamin C to them orally. When the patients failed to demonstrate improved survival over patients not receiving vitamin C in the study, Moertel pronounced the vitamin C/cancer hypothesis defunct. Moertel failed to note that the benefits achieved by Pauling and Cameron’s patients were obtained via both IV and oral C.




He ultimately succumbed to cancer himself years later. Alternative practitioners, meanwhile, sought to resurrect IV vitamin C as a tool in the treatment of cancer, but not until recently has serious academic research resumed. Dr. Hugh Riordan of Kansas treated hundreds of cancer patients with doses of vitamin C up to 200,000 mg (200 grams) per day in infusions lasting 4-12 hours several times a week. He compiled a series of case histories documenting impressive responses but passed recently, before his work was generally acknowledged. His protegee, Dr. Jeanne Drisko, Director, KU Integrative Medicine, has undertaken a series of clinical trials to validate the benefits of IV vitamin C in cancer. An FDA approved trial is now underway. Research at the National Institutes of Health is beginning to suggest that vitamin C deserves another chance to find its niche in the arsenal of anti-cancer therapies. Studies now suggest that even high dose vitamin C given by mouth is poorly absorbed.




Blood levels “max out” at doses of 500 mg given several times during the day. But vitamin C given intravenously is another story. When delivered in a “drip,” much higher concentrations of C can be attained. At these higher concentrations, vitamin C has different characteristics than if given orally. While oral vitamin C boosts immunity and assists tissue repair, it is too weak to do much to kill or inhibit cancer cells. But at high doses delivered directly into the bloodstream, it may act to increase levels of hydrogen peroxide deep in the tissues where cancer cells lurk. Peroxide-mediated killing is one of the white blood cells’ key mechanisms for fighting infection and cancer. Research currently under way has shown that high concentrations of vitamin C can stop the growth or even kill a wide range of cancer cells. Only intravenous administration of vitamin C can deliver the high doses found to be effective against cancer. IV vitamin C, when administered by a trained, experienced physician, is safe and well-tolerated, even at doses as high as 100,000 mg (100 grams) per day.

Report Page